Unlocking the cidal activity of echinocandins against Aspergillus fumigatus
解锁棘白菌素对烟曲霉的杀灭活性
基本信息
- 批准号:10179720
- 负责人:
- 金额:$ 47.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AnabolismAntifungal AgentsAspergillosisAspergillusAspergillus fumigatusBiological AssayCRISPR/Cas technologyCell WallClinicalCombined Modality TherapyComplexCoupledCyclic AMP-Dependent Protein KinasesDataDevelopmentEffectivenessEngineeringExhibitsFutureGenerationsGenesGeneticGenomeGerminationGoalsHyphaeImmune systemImmunocompromised HostIn VitroIncidenceIndividualIndustrial fungicideInfectionInjuryInterventionLibrariesMechanicsMediator of activation proteinModelingMoldsMutationPathway interactionsPatientsPharmaceutical PreparationsPhosphotransferasesPolyenesPredispositionProtein KinaseReportingReproduction sporesResearchResidual stateResistanceSeptateStressStructureTherapeuticTherapeutic AgentsTherapeutic InterventionTissuesToxic effectTreatment EfficacyTriazolesWorkbiological adaptation to stressdeletion libraryfungushigh-throughput drug screeningimprovedin vivomortalitymouse modelmutantnovelprogramsresponsetherapeutically effectivetranscription factortranscriptomicstreatment effect
项目摘要
Invasive aspergillosis (IA), caused mainly by A. fumigatus, is the most prevalent invasive mold infection of
immunocompromised individuals and is associated with mortality rates of 35-90%. Only three classes of anti-
Aspergillus drugs exist. The global rise of resistance to the triazole class and the unacceptably high patient
toxicity of the polyene class limits the use of two of these. The remaining class, the echinocandins, are generally
considered effective therapeutic agents as their target is fungus-specific (cell wall biosynthesis) and they exhibit
low toxicity. However, the echinocandins are not fungicidal for Aspergillus species and a paradoxical effect of
treatment, characterized by decreased drug effectiveness with increasing drug concentrations, has been
described both in vivo and in vitro. Likely due to these issues, high incidence breakthrough infections during
echinocandin therapy have been reported. Therefore, echinocandin use for IA is also limited. The discovery of
mechanisms essential for echinocandin stress adaptation and survival is expected to improve therapeutic
efficacy with these important compounds by identifying fungal targets for future combination therapies. To
delineate novel mechanisms orchestrating echinocandin stress responses, we recently completed the
generation of a protein kinase disruption mutant library in a wild type genetic background. This library was
constructed using CRISPR/Cas9 gene-editing to disrupt each of the 142 putative protein kinases encoded by
the A. fumigatus genome. A total of 118 non-essential, unique gene disruptions were achieved and subsequently
employed for in vitro echinocandin susceptibility assays. Our preliminary assays identified a total of 12 protein
kinase disruption mutants displaying 4- to >32-fold decreased minimum effective concentrations (MEC)
compared to the parental strain. We have discovered that two of these mutations, residing in the previously
uncharacterized SepL and SidB kinases, impart fungicidal anti-Aspergillus activity to multiple echinocandins.
These protein kinases are predicted to be core components of the Septation Initiation Network (SIN), a three-
kinase cascade that is necessary for septation in fungi. Our exciting preliminary data show that blocking septation
via loss of any single SIN kinase causes widespread hyphal damage and loss of viability in response to
echinocandin treatment. In addition, employing the sepL disruption mutant, we have found that echinocandin
therapy improves survival and eliminates residual tissue burden in a mouse model of IA. As septa are important
for the limitation of mechanical injury to hyphae, and the A. fumigatus SIN is completely uncharacterized,
exploration of this network is expected to reveal novel effectors of echinocandin stress survival. Our aims are to
identify core SIN components required for unlocking echinocandin cidal activity (Aim 1), define temporal
requirements for enhancement of echinocandin activity resulting from septation blockade (Aim 2), and to
delineate the SIN pathway-dependent septum construction machinery (Aim 3). Our work will identify the SIN
components with the highest potential for benefit when targeted in combination with echinocandin therapy.
侵袭性曲霉病(Invasive aspergillosis, IA)是世界上最常见的侵袭性霉菌感染,主要由烟曲霉引起
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jarrod R. Fortwendel其他文献
MOB-mediated regulation of septation initiation network (SIN) signaling is required for echinocandin-induced hyperseptation in emAspergillus fumigatus/em
棘白菌素诱导烟曲霉超分隔需要 MOB 介导的分隔起始网络(SIN)信号调节
- DOI:
10.1128/msphere.00695-23 - 发表时间:
2024-02-20 - 期刊:
- 影响因子:3.100
- 作者:
Harrison I. Thorn;Xabier Guruceaga;Adela Martin-Vicente;Ashley V. Nywening;Jinhong Xie;Wenbo Ge;Jarrod R. Fortwendel;Rebecca S. Shapiro - 通讯作者:
Rebecca S. Shapiro
emhapE/em and emhmg1/em Mutations Are Drivers of emcyp51A/em-Independent Pan-Triazole Resistance in an Aspergillus fumigatus Clinical Isolate
emhapE/em 和 emhmg1/em 突变是烟曲霉临床分离株中不依赖于 emcyp51A/em 的泛三唑抗性的驱动因素
- DOI:
10.1128/spectrum.05188-22 - 发表时间:
2023-05-18 - 期刊:
- 影响因子:3.800
- 作者:
Ana C. O. Souza;Wenbo Ge;Nathan P. Wiederhold;Jeffrey M. Rybak;Jarrod R. Fortwendel;P. David Rogers - 通讯作者:
P. David Rogers
Jarrod R. Fortwendel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jarrod R. Fortwendel', 18)}}的其他基金
Genetic Determinants of Aspergillus host-pathogen interactions
曲霉菌宿主-病原体相互作用的遗传决定因素
- 批准号:
10724816 - 财政年份:2023
- 资助金额:
$ 47.18万 - 项目类别:
Unlocking the cidal activity of echinocandins against Aspergillus fumigatus
解锁棘白菌素对烟曲霉的杀灭活性
- 批准号:
10378147 - 财政年份:2021
- 资助金额:
$ 47.18万 - 项目类别:
Unlocking the cidal activity of echinocandins against Aspergillus fumigatus
解锁棘白菌素对烟曲霉的杀灭活性
- 批准号:
10590730 - 财政年份:2021
- 资助金额:
$ 47.18万 - 项目类别:
Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus
非 cyp51A 突变介导的烟曲霉三唑耐药性
- 批准号:
10582526 - 财政年份:2020
- 资助金额:
$ 47.18万 - 项目类别:
Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus
非 cyp51A 突变介导的烟曲霉三唑耐药性
- 批准号:
9913275 - 财政年份:2020
- 资助金额:
$ 47.18万 - 项目类别:
Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus
非 cyp51A 突变介导的烟曲霉三唑耐药性
- 批准号:
10358515 - 财政年份:2020
- 资助金额:
$ 47.18万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
9282239 - 财政年份:2014
- 资助金额:
$ 47.18万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
8806512 - 财政年份:2014
- 资助金额:
$ 47.18万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
9205482 - 财政年份:2014
- 资助金额:
$ 47.18万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
8696215 - 财政年份:2014
- 资助金额:
$ 47.18万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 47.18万 - 项目类别:
Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
- 批准号:
2898887 - 财政年份:2023
- 资助金额:
$ 47.18万 - 项目类别:
Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
- 批准号:
22H02216 - 财政年份:2022
- 资助金额:
$ 47.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
- 批准号:
22K05337 - 财政年份:2022
- 资助金额:
$ 47.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
- 批准号:
2753345 - 财政年份:2022
- 资助金额:
$ 47.18万 - 项目类别:
Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
- 批准号:
20H03533 - 财政年份:2020
- 资助金额:
$ 47.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
- 批准号:
2456629 - 财政年份:2020
- 资助金额:
$ 47.18万 - 项目类别:
Studentship
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
- 批准号:
19K05738 - 财政年份:2019
- 资助金额:
$ 47.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
- 批准号:
2107517 - 财政年份:2018
- 资助金额:
$ 47.18万 - 项目类别:
Studentship